The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease

Clinics

Volumn 69, Issue 1, 2014, Pages 28-37

  Vasconcelos, Luciano de Gois ^a   Jackowski, Andrea Parolin ^a   de Oliveira, Maira Okada ^b   Ribeiro Flor, Yona Mayara ^a   Lino Souza, Altay Alves ^a   Amodeo Bueno, Orlando Francisco ^a   Dozzi Brucki, Sonia Maria ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Executive functions; Magnetic resonance imaging

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; HISTOLOGY; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC;

EID: 84892953157     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(01)05     Document Type: Article

References (53)

1. Stopford CL, Snowden JS, Thompson JC, Neary D. Variability in cognitive presentation of Alzheimer's disease. Cortex. 2008;44(2):185-95, http://dx.doi.org/10.1016/j.cortex.2005.11.002.
2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263-69, http://dx.doi.org/10.1016/j.jalz.2011.03.005.
3. Jurado MB, Rosselli M. The elusive nature of executive functions: a review of our current understanding. Neuropsychol Rev. 2007;17(3):213-33, http://dx.doi.org/10.1007/s11065-007-9040-z.
4. Stokholm J, Vogel A, Gade A, Waldemar G. Heterogeneity in executive impairment in patients with very mild Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;22(1):54-9, http://dx.doi.org/10.1159/000093262.
5. Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry. 2007;64(12):1443-50, http://dx.doi.org/10.1001/archpsyc.64.12.1443.
6. Johnson JK, Lui LY, Yaffe K. Executive Function, More Than Global Cognition, Predicts Functional Decline and Mortality in Elderly Women. J Gerontol A Biol Sci Med Sci. 2007;62(10):1134-41, http://dx.doi.org/10.1093/gerona/62.10.1134.
7. Cahn-Weiner DA, Boyle PA, Malloy PF. Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Appl Neuropsychol. 2002;9(3):187-91, http://dx.doi.org/10.1207/S15324826AN0903_8.
8. Musicco M, Salamone G, Caltagirone C, Cravello L, Fadda L, Lupo F, et al. Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2010;30(3):219-28, http://dx.doi.org/10.1159/000319533.
9. Koppel J, Goldberg TE, Gordon ML, Huey E, Davies P, Keehlisen L, et al. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis. Am J Geriatr Psychiatry. 2012;20(11):994-1000.
10. Mesulam MM. Frontal cortex and behavior. Ann Neurol. 1986;19(4):320-5, http://dx.doi.org/10.1002/ana.410190403.
11. Wolk DA, Dickerson BC. Alzheimer's Disease Neuroimaging Initiative. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(22):10256-61, http://dx.doi.org/10.1073/pnas.1001412107.
12. Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, et al. Executive deficits and regional brain metabolism in Alzheimer's disease. Int J Geriatr Psychiatry. 2010;25(11):1150-8.
13. Amanzio M, Torta DM, Sacco K, Cauda F, D'Agata F, Duca S, et al. Unawareness of deficits in Alzheimer's disease: role of the cingulate cortex. Brain. 2011;134(Pt 4):1061-76.
14. Bracco L, Bessi V, Piccini C, Mosconi L, Pupi A, Sorbi S. Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease. J Neurol. 2007;254(8):1052-65.
15. Dickerson BC, Wolk DA. Alzheimer's Disease Neuroimaging Initiative. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J Neurol Neurosurg Psychiatry. 2011;82(1):45-51, http://dx.doi.org/10.1136/jnnp.2009.199505.
16. Oliveira PP Jr, Nitrini R, Busatto G, Buchpiguel C, Sato JR, Amaro E Jr. Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease. J Alzheimers Dis. 2010;19(4):1263-72.
17. Im K, Lee JM, Seo SW, Yoon U, Kim ST, Kim YH, et al. Variations in cortical thickness with dementia severity in Alzheimer's disease. Neurosci Lett. 2008;436(2):227-31, http://dx.doi.org/10.1016/j.neulet.2008.03.032.
18. Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, et al. Alzheimer's Disease Neuroimaging Initiative. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain. 2009;132(Pt 8):2036-47, http://dx.doi.org/10.1093/brain/awp105.
19. Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, et al. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage. 2011;58(3):818-28, http://dx.doi.org/10.1016/j.neuroimage.2011.06.065.
20. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 2011;76(16):1395-1402, http://dx.doi.org/10.1212/WNL.0b013e3182166e96.
21. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653-9.
22. Almeida OP, Almeida SA. Reliability of the Brazilian version of the abbreviated form of Geriatric Depression Scale (GDS) short form. Arq Neuropsiquiatr. 1999;57(2B):421-6, http://dx.doi.org/10.1590/S0004-282X1999000300013.
23. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol. 1980;7(5):486-8, http://dx.doi.org/10.1002/ana.410070516.
24. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr. 2003;61(3B):777-81, http://dx.doi.org/10.1590/S0004-282X2003000500014.
25. Rabbitt P, Donlan C, Watson P, McInnes L, Bent N. Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. Psychol Aging. 1995;10(3):307-13, http://dx.doi.org/10.1037/0882-7974.10.3.307.
26. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323-9, http://dx.doi.org/10.1093/geronj/37.3.323.
27. Carthery-Goulart MT, Areza-Fegyveres R, Schultz RR, Okamoto I, Caramelli P, Bertolucci PH, et al. Cross-cultural adaptation of the Disability Assessment for Dementia (DAD). Arq Neuropsiquiatr. 2007;65(3B):916-9, http://dx.doi.org/10.1590/S0004-282X2007000500038.
28. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308-14, http://dx.doi.org/10.1212/WNL.44.12.2308.
29. Sunderland T, Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA, et al. Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989;37(8):725-9.
30. Ostrosky-Soli{dotless}́s F, Ardila A, Rosselli M. NEUROPSI: a brief neuropsychological test battery in Spanish with norms by age and educational level. J Int Neuropsychol Soc. 1999;5(5):413-33.
31. Wilson BA, Alderman N, Burguess PW, Emslie H, Evans JJ. Behavioural Assessment of the Dysexecutive Syndrome (BADS). Bury St Edmunds, U.K.: Thames Valley Test Company. Translation: Ricardo O. Souza, Sergio L. Schmidt, Rio de Janeiro, 1996.
32. FreeSurfer: automated tools for reconstruction of the brain's cortical surface from structural MRI data. Available from: http://surfer.nmr.mgh.harvard.edu, Accessed on February 07, 2013.
33. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Ségonne F, Salat DH, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex. 2004;14(1):11-22, http://dx.doi.org/10.1093/cercor/bhg087.
34. Haldane M, Cunningham G, Androutsos C, Frangou S. Structural brain correlates of response inhibition in Bipolar Disorder I. J Psychopharmacol. 2008;22(2):138-43, http://dx.doi.org/10.1177/0269881107082955.
35. Julkunen V, Niskanen E, Koikkalainen J, Herukka SK, Pihlajamaki M, Hallikainen M, et al. Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study. J Alzheimers Dis. 2010;21(4):1141-51.
36. Johnson JK, Pa J, Boxer AL, Kramer JH, Freeman K, Yaffe K. Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30(4):344-51, http://dx.doi.org/10.1159/000318836.
37. Takeda N, Terada S, Sato S, Honda H, Yoshida H, Kishimoto Y, et al. Wisconsin card sorting test and brain perfusion imaging in early dementia. Dement Geriatr Cogn Disord. 2010;29(1):21-7, http://dx.doi.org/10.1159/000261645.
38. Machulda MM, Senjem ML, Weigand SD, Smith GE, Ivnik RJ, Boeve BF, et al. Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks. J Int Neuropsychol Soc. 2009;15(3):372-82, http://dx.doi.org/10.1017/S1355617709090523.
39. Sánchez-Benavides G, Gómez-Ansón B, Quintana M, Vives Y, Manero RM, Sainz A, et al. Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment. J Int Neuropsychol Soc. 2010;16(5):836-45, http://dx.doi.org/10.1017/S135561771000069X.
40. Duarte A, Hayasaka S, Du A, Schuff N, Jahng GH, Kramer J, et al. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2006;406(1-2):60-5, http://dx.doi.org/10.1016/j.neulet.2006.07.029.
41. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Arch Neurol. 2006;63(1):38-46, http://dx.doi.org/10.1001/archneur.63.1.38.
42. Du AT, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, et al. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain. 2007;130(Pt 4):1159-66.
43. Ridgway GR, Lehmann M, Barnes J, Rohrer JD, Warren JD, Crutch SJ, et al. Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology. 2012;79(1):80-4, http://dx.doi.org/10.1212/WNL.0b013e31825dce28.
44. Kim DH, Newman AB, Hajjar I, Strotmeyer ES, Klein R, Newton E, et al. Retinal microvascular signs and functional loss in older persons: the cardiovascular health study. Stroke. 2011;42(6):1589-95, http://dx.doi.org/10.1161/STROKEAHA.110.605261.
45. Hoshi T, Yamagami H, Furukado S, Miwa K, Tanaka M, Sakaguchi M, et al. Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors. Eur J Neurol. 2010;17(9):1134-40.
46. Lee Y, Back JH, Kim J, Byeon H. Multiple socioeconomic risks and cognitive impairment in older adults. Dement Geriatr Cogn Disord. 2010;29(6):523-9, http://dx.doi.org/10.1159/000315507.
47. Millán-Calenti JC, Tubi{dotless}́o J, Pita-Fernández S, González-Abraldes I, Lorenzo T, Maseda A. Prevalence of cognitive impairment: effects of level of education, age, sex and associated factors. Dement Geriatr Cogn Disord. 2009;28(5):455-60, http://dx.doi.org/10.1159/000257086.
48. Instituto Brasileiro de Geografia e Estati{dotless}́stica, Si{dotless}́ntese de Indicadores Sociais-Uma Análise das Condições de Vida da População Brasileira, 2009. Available from: http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/indicadoresminimos/sinteseindicsociais2009/indic_sociais2009.pdf, Accessed on February 07, 2013.
49. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry. 2005;162(4):676-82.
50. Venneri A, McGeown WJ, Shanks MF. Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease. Neuroreport. 2005;16(2):107-10, http://dx.doi.org/10.1097/00001756-200502080-00006.
51. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev. 2009;(2):CD001191.
52. Arendt T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 2009;118(1):167-79, http://dx.doi.org/10.1007/s00401-009-0536-x.
53. Fuster JM, Bressler SL. Cognit activation: a mechanism enabling temporal integration in working memory. Trends Cogn Sci. 2012; 16(4):207-18, http://dx.doi.org/10.1016/j.tics.2012.03.005.